2002 Senate Bill 1517

Introduced in the Senate

Nov. 14, 2002

Introduced by Sen. Beverly Hammerstrom (R-17)

To require public disclosure of prescription drug advertising and marketing expenses by private pharmaceutical companies.

Referred to the Committee on Health Policy